Cullinan Therapeutics (CGEM) Change in Taxes (2022 - 2023)

Cullinan Therapeutics' (CGEM) quarterly Change in Taxes came in at -$4.2 million in Q2 2023, down 109.05% year-on-year from $46.5 million in Q2 2022, and down 5509.33% quarter-over-quarter from -$75000.0 in Q1 2023.

Cullinan Therapeutics (CGEM) Change in Taxes (2022 - 2023) Analysis & Trends

Cullinan Therapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at -$4.2 million for Q2 2023.

  • On a quarterly basis, Change in Taxes fell 109.05% year-over-year to -$4.2 million in Q2 2023; TTM through Mar 2024 was -$4.2 million, a 200.0% decrease from a year earlier, with the FY2023 full-year figure at -$4.3 million, down 200.0% from the prior year.
  • Change in Taxes slipped to -$4.2 million in Q2 2023 per CGEM's latest filing, from -$75000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $46.5 million in Q2 2022 and bottomed at -$35.1 million in Q3 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cullinan Therapeutics 368.65 Mn 368.65 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -4.21 Mn
Jun 30, 2023 -4.21 Mn
Mar 31, 2023 -75,000.00
Mar 31, 2023 -75,000.00
Dec 31, 2022 -7.12 Mn
Dec 31, 2022 -7.12 Mn
Sep 30, 2022 -35.10 Mn
Sep 30, 2022 -35.10 Mn
Jun 30, 2022 46.50 Mn
Jun 30, 2022 46.50 Mn